Wharton JT - Search Results

1

Vaccine implications of folate binding protein, a novel cytotoxic T lymphocyte-recognized antigen system in epithelial cancers.

Peoples GE, Anderson BW, Lee TV, Murray JL, Kudelka AP, Wharton JT, Ioannides CG. Peoples GE, et al. Among authors: wharton jt. Clin Cancer Res. 1999 Dec;5(12):4214-23. Clin Cancer Res. 1999. PMID: 10632363

2

Tumor cytolysis by lymphocytes infiltrating ovarian malignant ascites.

Ioannides CG, Platsoucas CD, Rashed S, Wharton JT, Edwards CL, Freedman RS. Ioannides CG, et al. Among authors: wharton jt. Cancer Res. 1991 Aug 15;51(16):4257-65. Cancer Res. 1991. PMID: 1868446

3

Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines.

Fisk B, Blevins TL, Wharton JT, Ioannides CG. Fisk B, et al. Among authors: wharton jt. J Exp Med. 1995 Jun 1;181(6):2109-17. doi: 10.1084/jem.181.6.2109. J Exp Med. 1995. PMID: 7539040 Free PMC article.

4

Oligopeptide induction of a cytotoxic T lymphocyte response to HER-2/neu proto-oncogene in vitro.

Fisk B, Chesak B, Pollack MS, Wharton JT, Ioannides CG. Fisk B, et al. Among authors: wharton jt. Cell Immunol. 1994 Sep;157(2):415-27. doi: 10.1006/cimm.1994.1238. Cell Immunol. 1994. PMID: 7915203

5

Changes in an HER-2 peptide upregulating HLA-A2 expression affect both conformational epitopes and CTL recognition: implications for optimization of antigen presentation and tumor-specific CTL induction.

Fisk B, Savary C, Hudson JM, O'Brian CA, Murray JL, Wharton JT, Ioannides CG. Fisk B, et al. Among authors: wharton jt. J Immunother Emphasis Tumor Immunol. 1995 Nov;18(4):197-209. doi: 10.1097/00002371-199511000-00001. J Immunother Emphasis Tumor Immunol. 1995. PMID: 8680648

6

Identification of naturally processed human ovarian peptides recognized by tumor-associated CD8+ cytotoxic T lymphocytes.

Fisk B, Anderson BW, Gravitt KR, O'Brian CA, Kudelka AP, Murray JL, Wharton JT, Ioannides CG. Fisk B, et al. Among authors: wharton jt. Cancer Res. 1997 Jan 1;57(1):87-93. Cancer Res. 1997. PMID: 8988046

7

Existent proliferative responses of peripheral blood mononuclear cells from healthy donors and ovarian cancer patients to HER-2 peptides.

Fisk B, Hudson JM, Kavanagh J, Wharton JT, Murray JL, Ioannides CG, Kudelka AP. Fisk B, et al. Among authors: wharton jt. Anticancer Res. 1997 Jan-Feb;17(1A):45-53. Anticancer Res. 1997. PMID: 9066629

8

Proliferative and cytokine responses to class II HER-2/neu-associated peptides in breast cancer patients.

Tuttle TM, Anderson BW, Thompson WE, Lee JE, Sahin A, Smith TL, Grabstein KH, Wharton JT, Ioannides CG, Murray JL. Tuttle TM, et al. Among authors: wharton jt. Clin Cancer Res. 1998 Aug;4(8):2015-24. Clin Cancer Res. 1998. PMID: 9717833

9

Ovarian cancer-associated lymphocyte recognition of folate binding protein peptides.

Peoples GE, Anderson BW, Fisk B, Kudelka AP, Wharton JT, Ioannides CG. Peoples GE, et al. Among authors: wharton jt. Ann Surg Oncol. 1998 Dec;5(8):743-50. doi: 10.1007/BF02303486. Ann Surg Oncol. 1998. PMID: 9869522

10

Ovarian and breast cytotoxic T lymphocytes can recognize peptides from the amino enhancer of split protein of the Notch complex.

Babcock B, Anderson BW, Papayannopoulos I, Castilleja A, Murray JL, Stifani S, Kudelka AP, Wharton JT, Ioannides CG. Babcock B, et al. Among authors: wharton jt. Mol Immunol. 1998 Dec;35(17):1121-33. doi: 10.1016/s0161-5890(98)00100-x. Mol Immunol. 1998. PMID: 10395201

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters